GWG Holdings Inc  

(Public, NASDAQ:GWGH)   Watch this stock  
Find more results for GWGH
8.60
-0.39 (-4.37%)
Feb 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.60 - 8.84
52 week 8.10 - 11.25
Open 8.84
Vol / Avg. 0.00/5,450.00
Mkt cap 49.98M
P/E     -
Div/yield     -
EPS -3.68
Shares 5.81M
Beta 0.37
Inst. own 0%
May 4, 2018
GWG Holdings Inc Annual Shareholders Meeting (Estimated) - 10:00AM EDT - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -27.64% 0.56%
Operating margin 43.88% 61.99%
EBITD margin - 61.99%
Return on average assets -2.23% 0.08%
Return on average equity - -
Employees 40 -
CDP Score - -

Address

220 S 6th St Ste 1200
MINNEAPOLIS, MN 55402-4512
United States - Map
+1-877-4942388 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

GWG Holdings, Inc. is the parent company of GWG Life, is a financial services company. The Company is focused on transforming the life insurance industry through its products and services. The Company has developed a new suite of options for the life insurance secondary market called LifeCare Xchange (LCX). This new capability provides seniors with the exchange value of their life insurance policies they can apply to long-term care and other post-retirement needs. Through its subsidiary GWG Life, LLC, seeks to further transform the industry by applying proprietary M-Panel epigenetic technology to disrupt traditional life insurance underwriting practices.

Officers and directors

Jon R. Sabes Chairman of the Board, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
William B. Acheson Chief Financial Officer
Age: 52
Bio & Compensation  - Reuters
Steven F. Sabes Executive Vice President - Originations and Servicing, Secretary, Director
Age: 49
Bio & Compensation  - Reuters
Chris Orestis Executive Vice President - Life Insurance Secondary Markets
Bio & Compensation  - Reuters
David H. Abramson Independent Director
Age: 75
Bio & Compensation  - Reuters
Shawn R. Gensch Independent Director
Age: 47
Bio & Compensation  - Reuters
Charles H. Maguire III Independent Director
Age: 73
Bio & Compensation  - Reuters
Jeffrey L. Mcgregor Independent Director
Age: 63
Bio & Compensation  - Reuters
Mark Schwarzmann Independent Director
Age: 55
Bio & Compensation  - Reuters